The GIFT Nifty futures were trading slightly in the green before the market’s opening on Thursday. Domestic Indices are expected to open on a similar flat-to-positive note.

Domestic equity indices, NSE Nifty 50 and S&P BSE Sensex, rose sharply on Wednesday over huge buying in FMCG, energy and capital goods amid mixed global cues. The Nifty advanced 121.50 points or 0.62% to close at 19,811.35, while the Sensex settled at 66,473.05 after advancing 0.6% or 393.69 points.

Here are some of the stocks that will be in the limelight on October 12.

Aurobindo Pharma: The pharma company’s wholly-owned subsidiary, CuraTeQ Biologics, has inked a Letter of Intent (LoI) with Merck Sharp & Dohme Singapore Trading Pte Ltd and its affiliates for contract manufacturing operations (CMO) for biologicals. The involved parties intend to conclude the negotiations by March 31, 2024.

Tata Consultancy Services: Tata Group’s IT services arm reported an 8.7% year-on-year increase in profit to Rs 11,380 crore in the September 30, 2023 quarter. The company’s revenue from operations stood at Rs 59,692 crore, a rise of 7.9% during the same period. Further, the board of the IT major approved a Rs 17,000 crore buyback at Rs 4,150 per share and an interim dividend of Rs 9 per equity share. 

Maruti Suzuki India: The company announced that it has started exports of its India-manufactured off-roader, the Jimny 5-Door, to Latin America, the Middle East, and Africa regions. Maruti Suzuki India now exports 17 vehicles across different segments. 

Cipla: InvaGen Pharmaceuticals Inc, a wholly-owned subsidiary of the drug manufacturer, has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) on the classification of the inspection conducted at its manufacturing facility in Central Islip Long Island, USA, as Voluntary Action Indicated.

Companies announcing quarterly results today: Anand Rathi Wealth, Angel One, HCL Technologies, HDFC AMC, Infosys, and Kesoram Industries.